Yüklüyor......
The full blood count as a biomarker of outcome and toxicity in ipilimumab‐treated cutaneous metastatic melanoma
Ipilimumab produces durable responses in some metastatic melanoma patients. Neutrophil, platelet, and eosinophil to lymphocyte ratios (NLR, PLR, and ELR) may be associated with the immune response in cancer thereby acting as biomarkers of toxicity and efficacy in ipilimumab‐treated patients. Data we...
Kaydedildi:
| Yayımlandı: | Cancer Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5083732/ https://ncbi.nlm.nih.gov/pubmed/27683208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.878 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|